Your browser doesn't support javascript.
loading
Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome.
Yoo, Jaeeun; Lee, Gun Dong; Kim, Jee Hae; Lee, Seung Nam; Chae, Hyojin; Han, Eunhee; Kim, Yonggoo; Kim, Myungshin.
Affiliation
  • Yoo J; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee GD; Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim JH; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee SN; Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Chae H; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Han E; Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim Y; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim M; Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ann Lab Med ; 40(2): 148-154, 2020 Mar.
Article in En | MEDLINE | ID: mdl-31650731
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: High-Throughput Nucleotide Sequencing / Hereditary Breast and Ovarian Cancer Syndrome Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Ann Lab Med Year: 2020 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: High-Throughput Nucleotide Sequencing / Hereditary Breast and Ovarian Cancer Syndrome Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Ann Lab Med Year: 2020 Type: Article